Replimune Initiates IPO & Sale of Common Stock and Pre-Funded Warrants

Replimune Group Inc. has entered into an underwriting agreement to sell an aggregate of 9,701,490 shares of common stock and pre-funded warrants for 2,736,340 additional shares. The offering is led by Leerink Partners LLC and J.P. Morgan Securities LLC, and could potentially increase the company's equity capitalization.